Central nervous system involvement in Wegener's granulomatosis;Atteinte cérébrale au cours d'une maladie de Wegener

Revue de Medecine Interne

Volumn 29, Issue 11, 2008, Pages 912-916

  Jouret, F ^a   Noirhomme, S ^a   Grandin, C ^a   Lonneux, M ^a   Godfraind, C ^a   Lambert, M ^a   Lefebvre, C ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Positron emission tomography; Syncope; Vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; DOTAREN; FLUORODEOXYGLUCOSE F 18; GADOTERIC ACID; METHYLPREDNISOLONE; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; MALE; POSITRON EMISSION TOMOGRAPHY; WEGENER GRANULOMATOSIS;

BIOPSY; BRAIN; CEREBROVASCULAR DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARANASAL SINUSES; TOMOGRAPHY, X-RAY COMPUTED; WEGENER GRANULOMATOSIS;

EID: 54049105294     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.04.003     Document Type: Article

References (15)

1. Rao J.K., Weinberger M., Oddone E.Z., Allen N.B., Landsman P., and Feussner J.R. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 123 (1995) 925-932
2. Seror R., Mahr A., Ramanoelina J., Pagnoux C., Cohen P., and Guillevin L. Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 85 (2006) 54-65
3. Konaté A., Le Falher G., Crozat-Grosleron S., Rivière S., and Le Quellec A. Incidence and presentation of the central neurological manifestations of Wegener's granulomatosis: a monocentric study of 14 cases. Rev Med Interne 25 (2004) 183-188
4. Nishino H., Rubino F.A., and Parisi J.E. The spectrum of neurologic involvement in Wegener's granulomatosis. Neurology 43 (1993) 1334-1337
5. de Groot K., Schmidt D.K., Arlt A.C., Gross W.L., and Reinhold-Keller E. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 58 (2001) 1215-1221
6. Silvera S., Vignaux O., and Legmann P. Sinonasal and cerebral imaging findings in Wegener's granulomatosis. Presse Med 36 (2007) 913-921
7. Murphy J.M., Gomez-Anson B., Gillard J.H., Antoun N.M., Cross J., Elliott J.D., et al. Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 213 (1999) 794-799
8. Raynaud F.R., Huglo D., and Steinling M. Positron emission tomography: current use in internal medicine and future perspectives. Rev Med Interne 27 (2006) 932-945
9. Meller J., Sahlmann C.O., and Scheel A.K. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48 (2007) 35-45
10. Dumarey N., Egrise D., Blocklet D., Stallenberg B., Remmelink M., del Marmol V., et al. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 47 (2006) 625-632
11. Jaruskova M., and Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 33 (2006) 913-918
12. Blockmans D., de Ceuninck L., Vanderschueren S., Knockaert D., Mortelmans L., and Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55 (2006) 131-137
13. Sossi V. Cutting-edge brain imaging with positron emission tomography. Neuroimaging Clin N Am 17 (2007) 427-440
14. Vandergheynst F., Goldman S., and Cogan E. Wegener's granulomatosis overlapping with Takayasu's arteritis revealed by FDG-PET scan. Eur J Intern Med 18 (2007) 148-149
15. Kariv R., Sidi Y., and Gur H. Systemic vasculitis presenting as a tumorlike lesion. Four case reports and an analysis of 79 reported cases. Medicine (Baltimore) 79 (2000) 349-359